亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Primary Immunodeficiency Diseases with BCG-Induced Diseases: A 15-Year Longitudinal Cohort Study

医学 原发性免疫缺陷 队列 造血干细胞移植 队列研究 儿科 免疫缺陷 内科学 回顾性队列研究 医学微生物学 公共卫生 移植 生存分析 疾病 年轻人 抗细菌 造血细胞 存活率 免疫学 重症监护医学 死亡率 流行病学 不利影响 前瞻性队列研究 病历 严重联合免疫缺陷
作者
Lu Xia,Yang Yang,Xueying Li,Ping Liu,Xiao-min Wang,Zhen Huang,Shui-hua Lu,Xu-hui Liu
出处
期刊:Journal of Clinical Immunology [Springer Science+Business Media]
标识
DOI:10.1007/s10875-026-01996-1
摘要

Children with primary immunodeficiency (PID) may develop severe infections after BCG vaccination. There is limited information on the long-term prognosis and management of these BCG-induced diseases. Data were gathered from a cohort study on BCG-induced diseases at the Shanghai Public Health Clinical Center, spanning from January 2007 to August 2022. The study enrolled patients with confirmed PIDs, and information was obtained via personal interviews with patients or their guardians, as well as from their medical records. This allowed us to gather clinical and genetic details, treatment history, and the outcomes of their PIDs. We evaluated antimycobacterial outcomes and analyzed the impact of HSCT and IFN-γ therapy on the risk of death. Out of 422 patients with BCG-induced diseases, 109 patients with confirmed PID were included in the analysis. Of these, 88.1% had developed distant or disseminated BCG infection, and the median duration of illness documented in the study was 57 months (IQR 31–79). The three most common PIDs in this cohort were MSMD (47/109, 43.1%), CGD (28/109, 25.7%), and CID (19/109 or 17.4%). The estimated five-year and ten-year survival rates were 80.3% (95%CI, 72.1%-88.5%) and 69.3% (95%CI, 56.8%-81.8%). Patients who received hematopoietic stem cell transplantation therapy (HSCT) had a significantly higher success rate with antimycobacterial treatment (75.8% vs. 0%). The survival benefit of HSCT varies across immunodeficiency types but is clearly beneficial for CID (p < 0.001). IFN-γ therapy presented no significant effect on the survival of CGD and MSMD. The initial STRONGkids nutritional score (HR = 2.27 per point, 95%CI 1.65–3.13) and gender (HR for male = 4.89, CI 1.36–17.57) are significant predictors of survival. Mutations in 6 genes (IL12RB1, CYBB, IFNGR1, IL2RG, STAT1, and RAG1) account for 66% of BCG-associated immunodeficiency mutations. PID complicated by BCG infection may cause persistent and severe conditions. Patients with severe nutritional risk in the early stages of infection have a higher risk of death and should prioritize HSCT.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
jyy完成签到,获得积分10
31秒前
丘比特的应助被科研通管家采纳,获得10
31秒前
null的应助被科研通管家采纳,获得10
31秒前
null的应助被科研通管家采纳,获得10
31秒前
jyy发布了新的文献求助50
41秒前
WhiteCaramel完成签到 ,获得积分10
52秒前
积极花瓣完成签到,获得积分10
55秒前
自觉的孤兰完成签到,获得积分10
57秒前
生性不爱说话完成签到,获得积分10
58秒前
1分钟前
山是山三十三完成签到 ,获得积分0
1分钟前
Michelle完成签到 ,获得积分10
1分钟前
怕孤单的雪瑶完成签到,获得积分10
1分钟前
wubin69发布了新的文献求助10
1分钟前
凶狠的映真完成签到,获得积分10
1分钟前
小蘑菇的应助被wubin69采纳,获得10
2分钟前
Ara完成签到,获得积分10
2分钟前
耍酷的手套完成签到,获得积分10
2分钟前
JamesPei的应助被oleskarabach采纳,获得10
2分钟前
2分钟前
敏感兰完成签到,获得积分10
2分钟前
zhanghao完成签到,获得积分10
2分钟前
ZZZ完成签到,获得积分10
3分钟前
breeze完成签到,获得积分10
3分钟前
善良凝荷完成签到,获得积分10
3分钟前
3分钟前
仁爱的如天完成签到,获得积分10
3分钟前
ZZZ发布了新的文献求助10
3分钟前
NexusExplorer的应助被houhoujiang采纳,获得10
3分钟前
Taso17发布了新的文献求助20
3分钟前
foxm完成签到,获得积分10
3分钟前
star发布了新的文献求助30
3分钟前
3分钟前
留胡子的鸿涛完成签到,获得积分10
3分钟前
自由乌冬面完成签到,获得积分10
4分钟前
4分钟前
houhoujiang发布了新的文献求助10
4分钟前
幽nigh完成签到 ,获得积分10
4分钟前
研友_VZG7GZ的应助被Taso17采纳,获得10
4分钟前
n01W97的应助被科研通管家采纳,获得20
4分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185149
求助须知:如何正确求助?哪些是违规求助? 9574052
关于积分的说明 21834129
捐赠科研通 7782677
什么是DOI,文献DOI怎么找? 3434531
关于科研通互助平台的介绍 2558763
邀请新用户注册赠送积分活动 2481208